Cargando…
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567053/ https://www.ncbi.nlm.nih.gov/pubmed/23408974 http://dx.doi.org/10.1371/journal.pone.0055362 |
_version_ | 1782258651576139776 |
---|---|
author | De Marco, Carmela Rinaldo, Nicola Bruni, Paola Malzoni, Carmine Zullo, Fulvio Fabiani, Fernanda Losito, Simona Scrima, Marianna Marino, Federica Zito Franco, Renato Quintiero, Alfina Agosti, Valter Viglietto, Giuseppe |
author_facet | De Marco, Carmela Rinaldo, Nicola Bruni, Paola Malzoni, Carmine Zullo, Fulvio Fabiani, Fernanda Losito, Simona Scrima, Marianna Marino, Federica Zito Franco, Renato Quintiero, Alfina Agosti, Valter Viglietto, Giuseppe |
author_sort | De Marco, Carmela |
collection | PubMed |
description | The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients for alterations in the members of the PI3K pathway. We report that AKT is significantly hyperactive in OC compared to normal tissue (n = 93; p<0.0001) and that AKT activation is preferentially observed in the elderly (>58 years old; n = 93; p<0.05). The most frequent alteration is the overexpression of the p110α catalytic subunit of PI3K (63/93, ∼68%); less frequent alterations comprise the loss of PTEN (24/89, 27%) and the overexpression of AKT1 (18/96, 19%) or AKT2 (11/88,12.5%). Mutations in the PIK3CA or KRAS genes were detected at lower frequency (12% and 10%, respectively) whereas mutations in AKT1 or AKT2 genes were absent. Although many tumors presented a single lesion (28/93, of which 23 overexpressed PIK3CA, 1 overexpressed AKT and 4 had lost PTEN), many OC (35/93) presented multiple alterations within the PI3K pathway. Apparently, aberrant PI3K signalling was mediated by activation of the canonical downstream AKT-dependent mTOR/S6K1/4EBP1 pathway and by regulation of expression of oncogenic transcription factors that include HMGA1, JUN-B, FOS and MYC but not by AKT-independent activation of SGK3. FISH analysis indicated that gene amplification of PIK3CA, AKT1 and AKT2 (but not of PI3KR1) and the loss of PTEN are common and may account for changes in the expression of the corresponding proteins. In conclusion, our results indicate that p110α overexpression represents the most frequent alteration within the PI3K/AKT pathway in OC. However, p110α overexpression may not be sufficient to activate AKT signalling and drive ovarian tumorigenesis since many tumors overexpressing PI3K presented at least one additional alteration. |
format | Online Article Text |
id | pubmed-3567053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35670532013-02-13 Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma De Marco, Carmela Rinaldo, Nicola Bruni, Paola Malzoni, Carmine Zullo, Fulvio Fabiani, Fernanda Losito, Simona Scrima, Marianna Marino, Federica Zito Franco, Renato Quintiero, Alfina Agosti, Valter Viglietto, Giuseppe PLoS One Research Article The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients for alterations in the members of the PI3K pathway. We report that AKT is significantly hyperactive in OC compared to normal tissue (n = 93; p<0.0001) and that AKT activation is preferentially observed in the elderly (>58 years old; n = 93; p<0.05). The most frequent alteration is the overexpression of the p110α catalytic subunit of PI3K (63/93, ∼68%); less frequent alterations comprise the loss of PTEN (24/89, 27%) and the overexpression of AKT1 (18/96, 19%) or AKT2 (11/88,12.5%). Mutations in the PIK3CA or KRAS genes were detected at lower frequency (12% and 10%, respectively) whereas mutations in AKT1 or AKT2 genes were absent. Although many tumors presented a single lesion (28/93, of which 23 overexpressed PIK3CA, 1 overexpressed AKT and 4 had lost PTEN), many OC (35/93) presented multiple alterations within the PI3K pathway. Apparently, aberrant PI3K signalling was mediated by activation of the canonical downstream AKT-dependent mTOR/S6K1/4EBP1 pathway and by regulation of expression of oncogenic transcription factors that include HMGA1, JUN-B, FOS and MYC but not by AKT-independent activation of SGK3. FISH analysis indicated that gene amplification of PIK3CA, AKT1 and AKT2 (but not of PI3KR1) and the loss of PTEN are common and may account for changes in the expression of the corresponding proteins. In conclusion, our results indicate that p110α overexpression represents the most frequent alteration within the PI3K/AKT pathway in OC. However, p110α overexpression may not be sufficient to activate AKT signalling and drive ovarian tumorigenesis since many tumors overexpressing PI3K presented at least one additional alteration. Public Library of Science 2013-02-07 /pmc/articles/PMC3567053/ /pubmed/23408974 http://dx.doi.org/10.1371/journal.pone.0055362 Text en © 2013 De Marco et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article De Marco, Carmela Rinaldo, Nicola Bruni, Paola Malzoni, Carmine Zullo, Fulvio Fabiani, Fernanda Losito, Simona Scrima, Marianna Marino, Federica Zito Franco, Renato Quintiero, Alfina Agosti, Valter Viglietto, Giuseppe Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma |
title | Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma |
title_full | Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma |
title_fullStr | Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma |
title_full_unstemmed | Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma |
title_short | Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma |
title_sort | multiple genetic alterations within the pi3k pathway are responsible for akt activation in patients with ovarian carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567053/ https://www.ncbi.nlm.nih.gov/pubmed/23408974 http://dx.doi.org/10.1371/journal.pone.0055362 |
work_keys_str_mv | AT demarcocarmela multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT rinaldonicola multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT brunipaola multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT malzonicarmine multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT zullofulvio multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT fabianifernanda multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT lositosimona multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT scrimamarianna multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT marinofedericazito multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT francorenato multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT quintieroalfina multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT agostivalter multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma AT vigliettogiuseppe multiplegeneticalterationswithinthepi3kpathwayareresponsibleforaktactivationinpatientswithovariancarcinoma |